David A. Brealey

机构：University College Hospital, University College London Hospitals NHS Foundation Trust, Bury College, UCL Biomedical Research Centre, University College London · ORCID：0000-0002-1982-3379

发表论文 184 篇 · 总被引 11512 次 · h-index 47

代表论文

• A second update on mapping the human genetic architecture of COVID-19 (2023 · Nature · 被引 126)
• Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis (2024 · JAMA · 被引 105)
• Landiolol and Organ Failure in Patients With Septic Shock (2023 · JAMA · 被引 105)
• Discontinuation vs. continuation of renin–angiotensin system inhibition before non-cardiac surgery: the SPACE trial (2023 · European Heart Journal · 被引 66)
• INHALE WP3, a multicentre, open-label, pragmatic randomised controlled trial assessing the impact of rapid, ICU-based, syndromic PCR, versus standard-of-care on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumonia (2025 · Intensive Care Medicine · 被引 48)
• Guidelines vs mindlines: a qualitative investigation of how clinicians’ beliefs influence the application of rapid molecular diagnostics in intensive care (2025 · Antimicrobial Agents and Chemotherapy · 被引 16)